Human papillomavirus among medical students at a federal public university
DOI:
https://doi.org/10.11606/issn.2176-7262.rmrp.2023.200480Keywords:
Papillomavirus vaccines, Papillomavirus infections, Papillomaviridae , Students medical, Vaccination coverageAbstract
OBJECTIVE: Analyze the vaccination status against the human papillomavirus among students at the School of Medicine of the Federal University of Juiz de Fora. METHODS: It is an observational cross-sectional study that aims to identify and analyze the characteristics and variables that relate to the vaccination status against the human papillomavirus of students at the School of Medicine of the Federal University of Juiz de Fora. The data were collected using standardized online questionnaires. RESULTS: Among the participants, 176 (49.2%) claimed to have been vaccinated against the virus and had received at least one dose of the vaccine. Among those surveyed, 74 (20.7%) students reported having taken 3 doses, while 89 (24.9%) took 2 and 13 (3.6%) took only 1 dose. Regarding the vaccinated in the age group covered by the public network, 62 (17.3%) are female (9-14 years old) and 12 (3.4%) are male (11-14 years old). A total of 66.66% of the students who have already had some injury by the virus, were not vaccinated. CONCLUSION: This study showed that, as with the Brazilian population in general, the vaccination status against human papillomavirus among students at the School of Medicine of the Federal University of Juiz de Fora is below expectations. The main reason reported for non-vaccination was not being part of the age group included in the vaccination of the public network. It was also found that the prevalence of lesions by Human Papillomavirus in vaccinated was lower than in non-vaccinated, emphasizing the need for the vaccine to prevent lesions caused by the virus.
Downloads
References
Sousa PDL e, Takiuti AD, Baracat EC, Sorpreso ICE, Abreu LC de. Conhecimento e aceitabilidade da vacina para o HPV entre adolescentes, pais e profissionais de saúde: elaboração de constructo para coleta e composição de banco de dados TT - Knowledge and acceptance of HPV vaccine among adolescents, parents and health p. Rev bras crescimento desenvolv hum [Internet]. 2018;28(1):58–68. Available from: http://pepsic.bvsalud.org/scielo.php?script=sci_arttext&%0Apid=S0104-12822018000100008
Brasil, Ministério da Saúde. Programa Nacional de Imunizações. PNI 25 anos. 1998 Brasília, Fundação Nacional de Saúde.
Brasil M da S. Informe técnico da ampliação da oferta das vacinas papilomavírus humano 6, 11, 16 e 18 (recombinante) – vacina HPV quadrivalente e meningocócica C (conjugada). Ministério da Saúde [Internet]. 2018;18:1–39. Available from: http://portalarquivos2.saude.gov.br/images/pdf/2018/marco/14/Informe-T--cnico-HPV-MENINGITE.pdf
Moura L de L, Codeço CT, Luz PM. Cobertura da vacina papilomavírus humano (HPV) no Brasil: heterogeneidade espacial e entre coortes etárias. Rev Bras Epidemiol. 2021;24.
Estudo Epidemiológico sobre a Prevalência Nacional de Infecção pelo HPV (POP-BRASIL) - 2015-2017 / Associação Hospitalar Moinhos de Vento. – Porto Alegre, 2020. 89 p
Manini I, Montomoli E. Epidemiology and prevention of Human Papillomavirus. Ann di Ig. 2018;30(4):28–32.
Crosbie EJ, Einstein MH, Franceschi S, Kitchener HC. Human papillomavirus and cervical cancer. Lancet [Internet]. 2013;382(9895):889–99. Available from: http://dx.doi.org/10.1016/S0140-6736(13)60022-7
Calumby RJN, Santos Silva RA, Suárez JAG, Lôbo T de LGF, Vieira DS, Silva KWL, et al. Papiloma Vírus Humano (HPV) e neoplasia cervical: importância da vacinação. Brazilian J Heal Rev. 2020;3(2):1610–28.
Brasil, Ministério da Saúde. OFÍCIO Nº 203/2021/CGPNI/DEIDT/SVS/MS, 03 de março de 2021;203(0019343807):30–2.
Febrasgo. Manual de Orientação Trato Genital Inferior. Fed Bras das Assoc Ginecol e Obs. 2010;Cap1; 2; 3:215.
Drolet M, Bénard É, Pérez N, Brisson M, Ali H, Boily MC, et al. Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis. Lancet. 2019;394(10197):497–509.
Harper DM, DeMars LR. HPV vaccines – A review of the first decade. Gynecol Oncol. 2017;146(1):196–204.
Fuzaro M, Cardial T, Roteli-martins CM, Naud P. Papilomavírus humano ( HPV ). Fed Bras das Assoc Ginecol e Obs 2017. 2019;47(2):94–100.
Biselli-Monteiro M, Ferracini AC, Sarian LO, Derchain SFM. Influence of Gender and Undergraduate Course on the Knowledge about HPV and HPV Vaccine, and Vaccination Rate among Students of a Public University TT - A influência do gênero e do curso de graduação no conhecimento sobre o HPV e sua vacina, e taxa de va. Rev Bras Ginecol e Obs [Internet]. 2020;42(2):96–105. Available from: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-72032020000200096&lang=pt%0Ahttp://www.scielo.br/pdf/rbgo/v42n2/1806-9339-rbgo-42-02-0096.pdf
Monteiro DLM, Brollo LCS, de Souza TP, Dos Santos JRP, Santos GR, Correa T, et al. Knowledge on the HPV vaccine among university students. Rev Inst Med Trop Sao Paulo. 2018;60(July):1–8.
Moro A, Santos CL, Couto MP de, Ávila LB de, Ditterich RG, Mazon LM. Coberturas vacinais do papiloma vírus humano no contexto brasileiro. Saúde e meio Ambient Rev Interdiscip. 2017;6(2):124.
De Almeida Silva S, Dos Anjos Sousa M do S, Rodrigues dos Santos Porto TN, De Sousa Santos EM, Stanford Baldoino L, Teixeira Feitosa G, et al. Situação vacinal do Papiloma Vírus Humano (HPV) em adolescentes em uma unidade básica de saúde no Maranhão. Rev Eletrônica Acervo Saúde. 2020;12(10):e4845.
Kops NL, Hohenberger GF, Bessel M, Correia Horvath JD, Domingues C, Kalume Maranhão AG, et al. Knowledge about HPV and vaccination among young adult men and women: Results of a national survey. Papillomavirus Res [Internet]. 2019;7(December 2018):123–8. Available from: https://doi.org/10.1016/j.pvr.2019.03.003
Kontos EZ, Emmons KM, Puleo E, Viswanath K. Contribution of communication inequalities to disparities in human papillomavirus vaccine awareness and knowledge. Am J Public Health. 2012;102(10):1911–20.
Brasil, Ministério da Saúde.Informe Técnico Sobre a Vacina Papilomavírus Humano (HPV) na Atenção Básica. Dezembro, 2013
Holman DM, Benard V, Roland KB, Watson M, Liddon N, Stokley S. Barriers to Human Papillomavirus Vaccination Among US Adolescents: A Systematic Review of the Literature. JAMA Pediatr [Internet]. 2014 Jan 1;168(1):76–82. Available from: https://doi.org/10.1001/jamapediatrics.2013.2752
Amadane M, De Pree C, Viviano M, Vassilakos P, Jeannot E, Petignat P. Characteristics of HPV-unvaccinated undergraduate health students in Switzerland, a cross sectional study. Arch Public Heal. 2019;77(1):1–6.
Santos MAP Dos, Fernandes FCG de M, Lima KC de, Barbosa IR. Desconhecimento sobre a campanha de vacinação contra o HPV entre estudantes brasileiros: uma análise multinível. Cien Saude Colet. 2021;26(12):6223–34.
Wright TC, Parvu V, Stoler MH, Kodsi S, Eckert K, Yanson K, et al. HPV infections and cytologic abnormalities in vaccinated women 21–34 years of age: Results from the baseline phase of the Onclarity trial. Gynecol Oncol [Internet]. 2019;153(2):259–65. Available from: https://doi.org/10.1016/j.ygyno.2019.02.016
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Denise Gasparetti Drumond, Laura Melo Werneck de Toledo, Marcella Barroso Marques Martins, Zínia Maria Mendes Dias
This work is licensed under a Creative Commons Attribution 4.0 International License.
